Literature DB >> 1654947

The octamer-binding protein Oct-2 represses HSV immediate-early genes in cell lines derived from latently infectable sensory neurons.

K A Lillycrop1, C L Dent, S C Wheatley, M N Beech, N N Ninkina, J N Wood, D S Latchman.   

Abstract

Transcription of herpes simplex virus (HSV) immediate-early (IE) genes does not occur in sensory neurons latently infected with the virus or following infection of neuronal cell lines. In neuronal cell lines this inability results from the weak activity of the viral IE promoters, which is caused by a neuron-specific repressor factor that binds specifically to the TAATGARAT motif in these promoters and to related octamer elements. Cells expressing this repressor contain an additional octamer-binding protein that is absent from permissive cells. We identify this factor as the lymphocyte- and neuron-specific octamer-binding protein Oct-2 and show that Oct-2 mRNA is also present in dorsal root ganglion neurons, the natural site of HSV latency in vivo. Moreover, artificially elevated expression of Oct-2 can repress the IE promoter. The potential role of Oct-2 in the initiation and maintenance of in vivo latent infection with HSV is discussed.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1654947     DOI: 10.1016/0896-6273(91)90290-g

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  46 in total

1.  A novel POU family transcription factor is closely related to Brn-3 but has a distinct expression pattern in neuronal cells.

Authors:  K A Lillycrop; V S Budrahan; N D Lakin; G Terrenghi; J N Wood; J M Polak; D S Latchman
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

2.  Association of ICP0 but not ICP27 with purified virions of herpes simplex virus type 1.

Authors:  F Yao; R J Courtney
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

3.  Immunohistochemical analysis of primary sensory neurons latently infected with herpes simplex virus type 1.

Authors:  L Yang; C C Voytek; T P Margolis
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Stress and reactivation of latent herpes simplex virus: a fusion of behavioral medicine and molecular biology.

Authors:  F J Jenkins; A Baum
Journal:  Ann Behav Med       Date:  1995

5.  The different alternatively spliced isoforms of the Oct-2 transcription factor repress the involucrin promoter in a cell type-specific manner.

Authors:  C M Chapman; D S Latchman
Journal:  Mol Biol Rep       Date:  1998-11       Impact factor: 2.316

6.  Gene delivery to rat enteric neurons using herpes simplex virus-based vectors.

Authors:  M K Howard; R S Coffin; A R Maclean; S M Brown; D Bailey; P N Anderson; G Burnstock; D S Latchman
Journal:  J Mol Neurosci       Date:  1997-10       Impact factor: 3.444

7.  The ability of POU family transcription factors to activate or repress gene expression is dependent on the spacing and context of their specific response elements.

Authors:  S J Dawson; Y Z Liu; B Rodel; T Möröy; D S Latchman
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

8.  Adjacent proline residues in the inhibitory domain of the Oct-2 transcription factor play distinct functional roles.

Authors:  Y Z Liu; I K Lee; I Locke; S J Dawson; D S Latchman
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

9.  Oct-2 transcription factor binding activity and expression up-regulation in rat cerebral ischaemia is associated with a diminution of neuronal damage in vitro.

Authors:  Susanna Camós; Carme Gubern; Mónica Sobrado; Rocío Rodríguez; Víctor G Romera; María Ángeles Moro; Ignacio Lizasoain; Joaquín Serena; Judith Mallolas; Mar Castellanos
Journal:  Neuromolecular Med       Date:  2013-11-27       Impact factor: 3.843

10.  Correlation between precolonization of trigeminal ganglia by attenuated strains of pseudorabies virus and resistance to wild-type virus latency.

Authors:  L M Schang; G F Kutish; F A Osorio
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.